Strong margins validated; domestic ramp-up ahead with execution risk

Delivered ₹85.2 Cr, +22.7% YoY (₹69.44 Cr Q1 FY26)

Delivered ₹5.1 Cr, +63.9% YoY; NPM 6.0% delivered vs 6.03% stated

EBITDA ₹8.64 Cr at 10.14% margin; prior ₹5.10 Cr at 7.35%. Operational efficiency gain corroborated.

Stated explicitly; implies Q1's 22.7% will decelerate, new facility minimal contribution (₹15–20 Cr from domestic)

Management guidance on 125–150 kg capacity studded jewelry mix (3–4 year ramp). Unverified, aspirational.

First time: new ₹27 Cr facility in Andheri for domestic B2B/B2C. Prior: export-only (40 years, 85–90% Middle East). Major diversification.

Currently <7% of revenue (mostly US), targeting significant domestic contributor via B2C. Nascent category in India; upside unproven but tailwind cited.

Revenue from USA fell from 20–30% (prior year) to <10% due to tariff headwinds. Now 'better performance' in FY27; recovery modest but positive.

85–90% of revenue still from Middle East (UAE, Saudi, Qatar, Kuwait, Bahrain). 20-year relationships intact; no major losses or gains mentioned.

Twofold: B2B supply to major retail chains (leveraging Middle East relationships) + B2C lab-grown jewelry focus. Positioning on studded jewellery vs competitors' plain gold.

No subsidiaries. Direct B2B to wholesalers, distributors, retailers across Middle East, USA, Europe. Asset-light model.

No specific named competitors. Market nascent; many entrants (branded retail + traditional jewelers). Big market ahead for multiple players globally.

Natural hedge for gold (import/export at same price). Forward contracts for diamonds 4–6 months based on receivables planning. Comprehensive coverage.

FY27: 15–20% (mostly export). By 2030: 50% domestic target; current ₹280 Cr exports + domestic = ₹550–600 Cr rough estimate.

₹250–300 Cr incremental capacity at peak (mix of caratage/metals/lab-grown). Mix dependent on gold pricing. Conservative estimate.

Rough calc: ₹280 Cr exports + 50% split = ₹550–600 Cr total.

Top 10: 60–65% of revenue.

<5–7% currently. Mostly US market. Middle East not active yet. Targeting India domestic as major contributor.

Hoping lab-grown 'significant contributor' in domestic; US exports improving this year after tariff hit. No specific $ target given.

All 500 are commercial-level (not prototype/creative). Some get multiple orders, some fewer. All production-ready.

Export: 10–11x inventory. Domestic expected similar or better (more competitive credit in export). Domestic should be easier to manage.

Export: hopeful to maintain. Domestic: EBITDA 'tighter initially' due to marketing push, but will reach similar margins over time.

Middle East: 85–90% of total (UAE, Saudi, Qatar, Kuwait, Bahrain). 20-year relationships, robust and consistent.

Minimal. Only Feb–Mar 2026 shipping disruption (~1 month). Air ops resumed after. Business and revenue not affected; numbers show strength.

Now <10% (down from 20–30% prior year). Tariff headwinds last year. Now stabilizing; better performance FY27.

No. Geopolitical risks high. Focusing on India domestic instead—better control, higher consumption. Export hedged by tailwinds.

40-year established company pivoting domestic. Lab-grown and retail opportunity in India. Raising capital, starting earnings call = serious commitment. Revenue >2x in 5 years expected.

Live now. Making samples for clients. No high volume current year. Seasonal ramp expected. Not waiting—active pitching phase.

₹15–20 Cr expected. Three years out: ₹250 Cr at peak capacity.

Diwali current year (Oct–Nov 2026) or pre-Diwali. Retail lounge (3rd floor) will kick-start B2C.

Different model than listed peers. Most peers do plain gold/CZ/diamonds. Golkunda focuses studded jewellery (natural + lab-grown). Differentiated.

B2C insignificant FY27. Over time, will become significant contributor. Requires brand-building time. No specific % target.

B2C should be 'definitely better' in margin. But too early to quantify—just starting.

New facility expected ₹15–20 Cr (3–8% of revenue). Domestic ramping; export stable. Conservative vs Q1's 22.7%.

Current ₹280 Cr exports + estimated domestic buildup. Assumes successful B2B/B2C execution. 2–3 year timeline. Aspirational.

Studded jewelry mix (carats, metals, lab-grown). Dependent on gold pricing and market mix. 'Shaded' by macro factors.

Management states hopeful to maintain. No specific target. Tariffs stable, costs under control.

Marketing push and ramp inefficiencies will compress margins initially. Long-term parity expected but unquantified timeline.

Aspirational. B2C upside unclear; brand building takes time. No baseline provided.

Capital already raised. Domestic facility operational; additional capex for 3rd floor retail lounge + WC for scaling.

Top 10 customers account for 60–65% of total revenue. Loss of single major retail partner would materially impact revenue. No customer diversification mentioned.

New facility (6 months old) still in sample/pitching phase. Expected ₹15–20 Cr FY27 contribution is 18–23% of new capacity potential. B2C launch Diwali 2026 unproven. Execution unvalidated.

US revenue fell from 20–30% to <10% due to tariffs. Hormuz shipping disruption (Feb–Mar 2026) caused 1-month pause. Management pivoting to domestic to hedge geopolitical risk.

Lab-grown <7% of revenue currently (mostly US). India market nascent; branded retail and traditional jewelers just entering. No specific revenue targets for lab-grown 3–5 years. Consumer adoption unproven.

Export inventory 10–11x cycles. Domestic expected similar or better. WC management critical as domestic scales. No cash flow statement provided.